神戸本社・東京支社（応相談） at Eli Lilly and Company

Kobe, Hyogo, Japan

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalsIndustries

Requirements

Japanese medical license (physician) with 5+ years of clinical experience
Specialization in diabetes internal medicine, endocrinology/metabolism internal medicine, cardiology internal medicine, etc
3+ years of practical treatment experience in obesity, diabetes, cardiovascular diseases, metabolic diseases, etc
Experience in paper/scientific publication writing
Leadership to lead teams as a medical expert while valuing teamwork
Smooth communication skills with internal and external customers
Business communication ability in English and Japanese
Presentation skills
Strategic and logical thinking abilities
Commute within 90km and 90 minutes by public transport from home nearest station (relocation required if not, with company housing available)

Responsibilities

Lead/support clinical development of new drugs (diabetes/obesity/cardiovascular/renal areas) in collaboration with related departments throughout the drug lifecycle (early development, approval, launch, post-marketing)
Support clinical trial implementation, lead preparation of application documents, support pharmaceutical affairs
Lead relationship building with key opinion leaders (KOLs) through opinion gathering and information sharing
Lead close collaboration with US headquarters and overseas team members
Lead publication of scientific data
Lead pre-launch preparation activities (including environment setup) from a medical expert perspective
Respond to medical/scientific inquiries from external customers (answer creation, on-site explanations)
Conduct discussions with external customers (including KOLs) on the drug
Lead scientific evidence creation for the drug (e.g., real-world evidence)
Plan and implement medical education activities for external customers (e.g., planning/operating educational lectures, creating materials)
Plan and implement medical planning (e.g., advisory board meetings)
Formulate strategies for post-marketing product value enhancement
Support sales/marketing team's business activities, including medical review of marketing tools and collaboration on brand strategy creation

Skills

Clinical Development

Medical Affairs

KOL Engagement

Scientific Publications

Clinical Trials

Medical Education

Strategic Planning

Leadership

Business Communication

Presentation Skills

Diabetes Treatment

Obesity Management

Cardiovascular Medicine

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free